Together, these capabilities give semiconductor companies a more evolutionary path from monolithic SoCs to multi-die architectures, while helping engineering teams improve design reuse, reduce integration complexity and bring differentiated products to market faster.
From monolithic designs to multi-die productsArteris customers are already using the company's technology as they transition existing architectures from single-die implementations to multi-die products.
"As Agentic AI workloads continue to expand across cloud infrastructure, edge and endpoint devices, multi-die architectures are becoming increasingly important for balancing performance, scalability, and development efficiency," said Jason Miller, senior director, Silicon Design at AMD. "Solutions that simplify system integration, while preserving bandwidth and performance across chiplets, help engineering teams accelerate innovation and bring differentiated products to market faster. Arteris' continued expansion of its multi-die portfolio supports the flexibility and productivity required for our next generation of data center, client, gaming, and embedded compute products."
"The future of advanced semiconductor design is inherently multi-die” said Daisuke Murakami, executive chief engineer, Global Leading Group at Socionext. By collaborating with Arteris on its UCIe-based multi-die solution, we gain early access to technologies that simplify chiplet integration while enabling the scalability, bandwidth and efficiency needed for next-generation AI, automotive and data-center SoCs."
Building toward a broader chiplet ecosystemAs multi-die adoption expands, interoperability among NoC technologies, die-to-die interfaces, chiplet IP, design tools and advanced packaging technologies will become increasingly important. Arteris is working with semiconductor IP and ecosystem partners to help reduce integration risk and establish more reusable foundations for multi-die design.
“Physical AI systems require right-sized inference and scalable architectures that seamlessly integrate diverse compute technologies while meeting stringent power, performance, safety, security, and reliability requirements,” said David Glasco, vice president of R&D, Silicon Solutions Group at Cadence. “By combining the comprehensive Cadence Physical AI platform, IP, and security solutions with Arteris’ NoC IP, our collaboration enables accelerated silicon realization and trusted system deployment from cloud to edge. This reusable foundation helps customers scale physical AI systems more efficiently, reduce development risk, and speed time to market. Together, Cadence and Arteris provide a seamless path from specification to silicon to deployment, accelerating innovation across the physical AI ecosystem.”
“An open chiplet ecosystem requires architectural frameworks that simplify the integration of specialized dies into scalable, manufacturable systems,” said Suresh Subramaniam Ph.D., CTO, systems and advanced packaging at Silitronics. “We plan to leverage Arteris FlexGen technology in our development of an OCP-derived chiplet architecture, combining intelligent die-to-die connectivity with Silitronics’ system-level design, advanced packaging and heterogeneous integration capabilities to help customers bring differentiated multi-die solutions to market faster.”
“As multi-die designs become increasingly central to AI and high-performance computing innovation, interoperability across the chiplet ecosystem is critical to reducing design complexity and accelerating adoption,” said Neeraj Paliwal, senior vice president of product management at Synopsys. “The successful validation of interoperability between Synopsys' silicon-proven UCIe IP, delivering high-bandwidth, low-latency die-to-die connectivity, and Arteris Ncore Cache Coherent NoC IP for multi-die designs helps customers confidently integrate chiplets, reduce integration risk, and enable silicon success.”
“UCIe provides an open, high-performance foundation for integrating chiplets across different functions and process technologies,” said Mao Liu, vice president at UniVista. “By working with Arteris to validate interoperability between UniVista UCIe IP and Arteris Ncore Multi-Die, we aim to provide customers with a more integrated path to scalable, cache-coherent multi-die designs for AI, high-performance computing and other compute-intensive applications.”
A practical path to the chiplet futureAI compute systems of the future require the transparent data movement solutions that Arteris is bringing to the industry, to speed the development and delivery of advanced heterogeneous systems. The new FlexGen Multi-Die product transparently extends non-coherent connectivity across die boundaries, enabling engineering teams to address different connectivity requirements across future multi-die SoC implementations.
The expanded Arteris multi-die solution is available today to early access partners and strategic customers. Learn more at
arteris.com/multi-die.
About ArterisArteris is a leading provider of semiconductor technology that accelerates the creation of high-performance, power-efficient silicon with built-in safety, reliability, and security. Innovative Arteris products are designed to optimize data movement and help ease complexity in the modern AI era with network-on-chip (NoC) interconnect intellectual property (IP), system-on-chip (SoC) software for integration automation and hardware security assurance. All are used by the world's top technology companies to improve overall performance and engineering productivity, reduce risk, lower costs, and bring cutting-edge designs to market faster. Learn more at
arteris.com.
© 2004-2026 Arteris, Inc. All rights reserved worldwide. Arteris, Arteris IP, the Arteris IP logo, and the other Arteris marks found at arteris.com/trademarks are trademarks or registered trademarks of Arteris, Inc. or its subsidiaries. All other trademarks are the property of their respective owners.*Not available in all markets.
Forward-Looking StatementsThis press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the Company’s expectations, plans, objectives, outlook, projected financial or operating results, market opportunities, product development, and/or business strategy. These statements are based on management’s current expectations, estimates, assumptions, and projections and are not historical facts. Words such as “may,” “will,” “could,” “would,” “expect,” “anticipate,” “believe,” “estimate,” “plan,” “intend,” “project,” “potential,” and similar expressions are intended to identify forward-looking statements.
These statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied, including economic and market conditions; supply-chain constraints; technological developments; regulatory changes; litigation; cybersecurity risks; availability of capital; and other risks. Additional information regarding these and other risks is included in the Company’s filings with the Securities and Exchange Commission.
The forward-looking statements speak only as of the date of this press release. The Company undertakes no obligation to update or revise any forward-looking statement, except as required by applicable law.
Media Contact:
Gina Jacobs
Arteris
+1 408 560 3044
newsroom@arteris.comThis press release was published by a CLEAR® Verified individual.
SOURCE: Arteris, Inc.
--BERNAMA